Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for Pedmark

Research Triangle Park, NC, June 22, 2021– Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the resubmission of...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news